Medical devices, healthcare technology and the business of care
510(k) clearance · K263086

AltiVate Reverse Glenosphere with RAVN Technology

ENCORE MEDICAL, L.P. · Decision date Oct 2, 2026

MEDTECHLEDGER EXPLANATIONK263086

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-02 for K263086, the AltiVate Reverse® Glenosphere with RAVN™ Technology, submitted by Encore Medical L.P. of Austin, TX. The device falls under regulation 888.3660, device classification name Shoulder Prosthesis, Reverse Configuration, with classification product code PHX and subsequent product code KWS; the regulation medical specialty and 510(k) review panel are both Orthopedic. The application was received 09/02/2026 and was not reviewed by a third party.

SESE in the 510(k) pathway denotes clearance as substantially equivalent to a predicate, not premarket approval of a new device. The record does not describe the specific component change, the predicate device, or any clinical data supporting the comparison; those details would sit in the underlying 510(k) review documents rather than the summary page. The page also lists no combination product status and no authorized predetermined change control plan, and the public record carries no statement text.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 2, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263086
Regulatory pathway
510(k) premarket notification
Product code
PHX
Decision code
SESE
Decision date
Oct 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Shoulder Prosthesis, Reverse Configuration.

Product code
PHX
FDA device class
2

FDA decision timeline

  1. K263086 received

    Application receipt date recorded by FDA.

  2. K263086 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code PHX

Product / regulatory recordCompanyPathwayDecision dateSource
FX Shoulder Solutions, Inc.510(k) clearanceNov 5, 2026FDA
restor3d Inc.510(k) clearanceOct 22, 2026FDA
Restor3D510(k) clearanceMay 19, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

ENCORE MEDICAL, L.P.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Austin, TX

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records